Awarded contract

Published

Blood Group Genotyping for Sickle Cell and Thalassaemi

6 suppliers have saved this notice.

Looks like a fit? Save this tender and qualify it in Stotles

Value

140,671 GBP

Current supplier

NHS Blood and transplant (NHS030)

Description

The main output of this programme is for blood group genotyping to become embedded into routine practice. Primary objective (benefit) of doing so is to ensure patients with rare blood disorders have a minimise risk of adverse reactions through access to blood group genotyping.

Never miss a tender again

Get alerts, AI summaries and tools to qualify faster

Explore similar pre-tenders, open or awarded contracts

Browse open tenders, recent contract awards and upcoming contract expiries that match similar CPV codes.

NHS Blood and Transplant

53,000,000

Published 18 days ago

South Tees Hospitals NHS Foundation Trust

375,000 GBP

Published a month ago

Birmingham City Council

1,125,576 GBP

Published 2 months ago

Norfolk and Norwich University Hospitals NHS Foundation Trust

200,000 GBP

Published 3 months ago

NHS North East and North Cumbria Integrated Care Board

372,631 GBP

Published 4 months ago

NHS North East and North Cumbria Integrated Care Board

269,526 GBP

Published 4 months ago

NHS Blood and Transplant

6,240,000 GBP

Published 4 months ago

NHS Blood and Transplant

8,655,000

Published 4 months ago

NHS Blood and Transplant

6,240,000 GBP

Published 4 months ago

Sign up to the Stotles Tender Tracker for free

Find even more contracts with advanced search capability and AI powered relevance scoring.